DHG Pharmaceutical JSC (HOSE: DHG)
Vietnam
· Delayed Price · Currency is VND 107,400
0.00 (0.00%)
At close: Oct 1, 2024
DHG Pharmaceutical JSC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 841,077 | 1,050,663 | 988,455 | 777,220 | 739,875 | 635,388 | Upgrade
|
| Depreciation & Amortization | 96,702 | 87,720 | 81,001 | 82,564 | 88,197 | 88,711 | Upgrade
|
| Other Amortization | 1,508 | 984.1 | - | 1,299 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -174,206 | -203,609 | -112,319 | -106,218 | -136,185 | -122,668 | Upgrade
|
| Other Operating Activities | -810.64 | -11,828 | -56,715 | -43,544 | -18,164 | -10,324 | Upgrade
|
| Change in Accounts Receivable | 10,258 | -268,589 | 34,206 | 22,427 | 69,743 | 119,150 | Upgrade
|
| Change in Inventory | 99,032 | -286,890 | -177,950 | -246,313 | -101,120 | 165,771 | Upgrade
|
| Change in Accounts Payable | -109,030 | -129,051 | 160,321 | -33,242 | 171,398 | -41,252 | Upgrade
|
| Change in Other Net Operating Assets | 4,446 | 772.15 | -15,714 | -1,749 | 12,430 | 3,464 | Upgrade
|
| Operating Cash Flow | 768,976 | 240,171 | 901,285 | 452,444 | 826,174 | 838,240 | Upgrade
|
| Operating Cash Flow Growth | 51.51% | -73.35% | 99.20% | -45.24% | -1.44% | 188.26% | Upgrade
|
| Capital Expenditures | -319,068 | -486,343 | -233,992 | -24,562 | -88,805 | -57,101 | Upgrade
|
| Sale of Property, Plant & Equipment | 1,995 | 1,654 | 3,334 | 4,632 | 5,238 | 11,584 | Upgrade
|
| Investment in Securities | - | - | 3,206 | 84.72 | 8,629 | - | Upgrade
|
| Other Investing Activities | 216,571 | 179,869 | 118,723 | 101,430 | 132,792 | - | Upgrade
|
| Investing Cash Flow | -430,501 | -179,819 | -353,729 | 45,694 | -248,092 | -223,655 | Upgrade
|
| Short-Term Debt Issued | - | 1,524,390 | 737,941 | 794,683 | 736,698 | 1,916,023 | Upgrade
|
| Total Debt Issued | 1,860,174 | 1,524,390 | 737,941 | 794,683 | 736,698 | 1,916,023 | Upgrade
|
| Short-Term Debt Repaid | - | -1,066,949 | -830,609 | -799,564 | -789,094 | -2,209,258 | Upgrade
|
| Total Debt Repaid | -1,670,502 | -1,066,949 | -830,609 | -799,564 | -789,094 | -2,209,258 | Upgrade
|
| Net Debt Issued (Repaid) | 189,671 | 457,441 | -92,668 | -4,880 | -52,395 | -293,234 | Upgrade
|
| Common Dividends Paid | -522,984 | -457,611 | -457,611 | -522,984 | -522,984 | -326,865 | Upgrade
|
| Financing Cash Flow | -333,313 | -170.11 | -550,279 | -527,865 | -575,380 | -620,100 | Upgrade
|
| Foreign Exchange Rate Adjustments | 56.6 | -65.74 | -222.19 | 45.25 | 23.7 | 7.57 | Upgrade
|
| Net Cash Flow | 5,218 | 60,116 | -2,946 | -29,681 | 2,726 | -5,507 | Upgrade
|
| Free Cash Flow | 449,908 | -246,171 | 667,293 | 427,882 | 737,369 | 781,139 | Upgrade
|
| Free Cash Flow Growth | 140.15% | - | 55.95% | -41.97% | -5.60% | 212.52% | Upgrade
|
| Free Cash Flow Margin | 9.00% | -4.91% | 14.27% | 10.69% | 19.63% | 20.05% | Upgrade
|
| Free Cash Flow Per Share | 3441.08 | -1882.82 | 5103.73 | 3272.62 | 5639.70 | 5974.47 | Upgrade
|
| Cash Interest Paid | 27,155 | 29,299 | 12,558 | 12,050 | 14,279 | 22,858 | Upgrade
|
| Cash Income Tax Paid | 78,778 | 104,854 | 100,999 | 99,613 | 78,841 | 65,982 | Upgrade
|
| Levered Free Cash Flow | 899,573 | -506,459 | 447,363 | 260,730 | 662,163 | 918,877 | Upgrade
|
| Unlevered Free Cash Flow | 916,410 | -488,003 | 455,212 | 268,280 | 670,932 | 933,074 | Upgrade
|
| Change in Net Working Capital | -589,643 | 748,040 | 64,346 | 329,011 | -165,780 | -469,329 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.